ArticleScientific reports2020
Theoretical analysis of a circular hybrid plasmonic waveguide to design a hybrid plasmonic nano-antenna.
Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A directional nanoantenna design based on a hybrid plasmonic waveguide: theoretical analysis for biosensing applications.Scientific reports · 2026Article
- Design of a square-horn hybrid plasmonic nano-antenna array using a flat lens for optical wireless applications with beam-steering capabilities.Scientific reports · 2024Article
- Beam-steering of dielectric flat lens nanoantenna with elliptical patch based on antenna displacement for optical wireless applications.Scientific reports · 2023Article
- Article
- Smart optical cross dipole nanoantenna with multibeam pattern.Scientific reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this paper, a circular hybrid plasmonic waveguide-fed nano-antenna (CHPWFNA) has been introduced for operating at the standard telecommunication wavelength of 1,550 nm. For the first time, the dispersion relation of a circular hybrid plasmonic waveguide as the feed line of the proposed nano-antenna has been derived, analytically. To verify the accuracy of the analytical solution, two numerical techniques of finite element method (FEM) and finite-difference time-domain (FDTD) method have been used. Numerical results are well-matched with the theoretical ones. The characteristics of the CHPWFNA have been studied by two mentioned methods. The obtained realized gains (directivities) by the FDTD and FEM simulations are 9.03 dB (9.38 dBi) and 10.00 dB (10.32 dBi), respectively, at 1,550 nm wavelength. For on-chip point-to-point wireless link performance, the obtained quality factor by the FDTD method (FEM) is 63.97 (100). The obtained radiation characteristics and link performance reveal that at 1,550 nm, the proposed antenna has the best performance. Besides, the frequency bandwidth of the antenna (185-200 THz) covers the low-loss optical frequency range. Also, paying attention to the laser eye safety is so important. Consequently, the wavelength of 1,550 nm has been chosen as the target wavelength. Moreover, the array configuration has been studied and the directivity and realized gain have been obtained based on the array factor theory and numerical methods, which are agree with each other. The attained realized gain by the FDTD method (FEM) for the considered single row array, at 1,550 nm, is 11.20 dB (11.30 dB). There is a little difference between the numerical results due to the total mesh size, the grid size refinement and the relative error of the numerical methods convergence. Finally, as one of the most important challenges in fabrication is the gold surface quality, we have studied the effect of gold surface roughness and its pentagonal cross section on the antenna performance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.